Jilin Jian Yisheng Pharmaceutical Co Ltd (002566) — Cash Flow-to-Debt Ratio
Jilin Jian Yisheng Pharmaceutical Co Ltd (002566) has a Cash Flow-to-Debt Ratio of 0.01x as of September 2025, meaning its operating cash flow of CN¥8.20 Million could theoretically repay 0% of its total liabilities (CN¥658.86 Million) in one year. Check how aggressively does Jilin Jian Yisheng Pharmaceutical Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Jilin Jian Yisheng Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2006–2025)
Historical debt coverage capacity for Jilin Jian Yisheng Pharmaceutical Co Ltd across 20 annual periods. Also explore balance sheet size of Jilin Jian Yisheng Pharmaceutical Co Ltd for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Jilin Jian Yisheng Pharmaceutical Co Ltd (2006–2025)
Year-by-year debt coverage analysis for Jilin Jian Yisheng Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see market value of Jilin Jian Yisheng Pharmaceutical Co Ltd.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | CN¥98.74 Million | CN¥630.35 Million | ▲ +69.3% |
| 2024 | 0.09x | CN¥58.94 Million | CN¥637.22 Million | ▼ -68.4% |
| 2023 | 0.29x | CN¥209.13 Million | CN¥714.30 Million | ▲ +44.0% |
| 2022 | 0.20x | CN¥145.86 Million | CN¥717.18 Million | ▼ -37.0% |
| 2021 | 0.32x | CN¥215.10 Million | CN¥666.08 Million | ▲ +5.3% |
| 2020 | 0.31x | CN¥203.51 Million | CN¥663.86 Million | ▼ -36.2% |
| 2019 | 0.48x | CN¥210.87 Million | CN¥438.66 Million | ▲ +68.8% |
| 2018 | 0.28x | CN¥167.32 Million | CN¥587.49 Million | ▼ -20.4% |
| 2017 | 0.36x | CN¥270.65 Million | CN¥756.40 Million | ▲ +1875.9% |
| 2016 | -0.02x | CN¥-17.52 Million | CN¥869.67 Million | ▲ +94.5% |
| 2015 | -0.36x | CN¥-324.29 Million | CN¥888.65 Million | ▲ +54.4% |
| 2014 | -0.80x | CN¥-592.06 Million | CN¥739.24 Million | ▲ +9.1% |
| 2013 | -0.88x | CN¥-188.45 Million | CN¥213.79 Million | ▼ -181.2% |
| 2012 | 1.09x | CN¥79.08 Million | CN¥72.81 Million | ▲ +162.5% |
| 2011 | -1.74x | CN¥-112.12 Million | CN¥64.52 Million | ▼ -633.3% |
| 2010 | 0.33x | CN¥50.73 Million | CN¥155.66 Million | ▼ -61.8% |
| 2009 | 0.85x | CN¥125.25 Million | CN¥146.67 Million | ▲ +430.9% |
| 2008 | 0.16x | CN¥20.50 Million | CN¥127.43 Million | ▼ -73.5% |
| 2007 | 0.61x | CN¥82.66 Million | CN¥136.08 Million | ▲ +135.9% |
| 2006 | 0.26x | CN¥25.58 Million | CN¥99.35 Million | — |